Otonomy, Inc. (OTIC) was a big mover last session, as the company saw its shares rise almost 9% on the day. The share price gain came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 13.5% since Jun 10, 2015.
The company has seen no estimate revisions in the past 30 days, but its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Otonomy. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Otonomy currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A better-ranked biotechnology stock is Nutraceutical International Corporation (NUTR), sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment